![Marek SRAMKO | Head of Department | MD, PhD, FESC | Institute for Clinical and Experimental Medicine (IKEM), Prague | IKEM | Department of Acute Cardiology | Research profile Marek SRAMKO | Head of Department | MD, PhD, FESC | Institute for Clinical and Experimental Medicine (IKEM), Prague | IKEM | Department of Acute Cardiology | Research profile](https://i1.rgstatic.net/ii/profile.image/854147591069696-1580656063563_Q512/Marek-Sramko.jpg)
Marek SRAMKO | Head of Department | MD, PhD, FESC | Institute for Clinical and Experimental Medicine (IKEM), Prague | IKEM | Department of Acute Cardiology | Research profile
![Jak na těžkosti s hernií aneb s kýlou do Frýdlantu třeba i v sobotu | Zdraví | Zprávy | Liberecká Drbna - zprávy z Liberce a Libereckého kraje Jak na těžkosti s hernií aneb s kýlou do Frýdlantu třeba i v sobotu | Zdraví | Zprávy | Liberecká Drbna - zprávy z Liberce a Libereckého kraje](https://liberecka.drbna.cz/files/drbna/images/page/2017/02/24/1000x1000-1487932668-foto-mudr-lukas-kohoutek-s-kolegyni-petrou-plechacovou.jpg)
Jak na těžkosti s hernií aneb s kýlou do Frýdlantu třeba i v sobotu | Zdraví | Zprávy | Liberecká Drbna - zprávy z Liberce a Libereckého kraje
![Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry | SpringerLink Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11523-014-0343-8/MediaObjects/11523_2014_343_Fig3_HTML.gif)